198 related articles for article (PubMed ID: 1087180)
21. Reversal of the in vitro methotrexate suppression of cell-mediated immune response by folinic acid and thymidine plus hypoxanthine.
Bogyo D; Mihich E
Cancer Res; 1980 Mar; 40(3):650-4. PubMed ID: 6970615
[TBL] [Abstract][Full Text] [Related]
22. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
Piper AA; Nott SE; Mackinnon WB; Tattersall MH
Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
[TBL] [Abstract][Full Text] [Related]
23. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
24. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
Goldman ID; Matherly LH
NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
[TBL] [Abstract][Full Text] [Related]
25. Toxicity of trimetrexate on hemopoietic progenitor cells in normal mice.
Bogliolo GV; Lerza RA; Mencoboni MP; Saviane AG; Pannacciulli IM
Anticancer Res; 1988; 8(2):229-31. PubMed ID: 2966606
[TBL] [Abstract][Full Text] [Related]
26. Leucovorin antagonizes the effects of trimetrexate on mouse hemopoietic progenitors.
Lerza R; Mencoboni M; Bogliolo G; Flego G; Gasparini L; Pannacciulli I
Anticancer Res; 1991; 11(2):613-6. PubMed ID: 1829599
[TBL] [Abstract][Full Text] [Related]
27. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
[TBL] [Abstract][Full Text] [Related]
28. Interference with nucleoside transport in mouse lymphoma cells proliferating in culture.
Warnick CT; Muzik H; Paterson AR
Cancer Res; 1972 Oct; 32(10):2017-22. PubMed ID: 4673140
[No Abstract] [Full Text] [Related]
29. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
30. Amelioration by leucovorin of methotrexate developmental toxicity in rabbits.
DeSesso JM; Goeringer GC
Teratology; 1991 Mar; 43(3):201-15. PubMed ID: 2014483
[TBL] [Abstract][Full Text] [Related]
31. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
32. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
Reid CD; Stackpoole A; Meager A; Tikerpae J
J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
[TBL] [Abstract][Full Text] [Related]
33. Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.
Pannacciulli I; Massa G; Bogliolo G; Ghio R; Sobrero A
Cancer Res; 1982 Feb; 42(2):530-4. PubMed ID: 6976827
[TBL] [Abstract][Full Text] [Related]
34. [In vitro cytotoxicity of methotrexate].
Maehara S
Nihon Seikeigeka Gakkai Zasshi; 1984 Jul; 58(7):677-84. PubMed ID: 6334123
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and cell cycle perturbations in methotrexate-treated cells.
Taylor IW; Slowiaczek P; Francis PR; Tattersall MH
Mol Pharmacol; 1982 Jan; 21(1):204-10. PubMed ID: 6982394
[TBL] [Abstract][Full Text] [Related]
37. Relative biochemical aspects of low and high doses of methotrexate in mice.
Zaharko DS; Fung WP; Yang KH
Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175
[TBL] [Abstract][Full Text] [Related]
38. Purine modulation of methotrexate cytotoxicity in mammalian cell lines.
Taylor IW; Slowiaczek P; Francis PR; Tattersall MH
Cancer Res; 1982 Dec; 42(12):5159-64. PubMed ID: 6958362
[TBL] [Abstract][Full Text] [Related]
39. Leucovorin rescue of human cancer and bone marrow cells following edatrexate or methotrexate.
Jolivet J; Jansen G; Peters GJ; Pinard MF; Schornagel JH
Biochem Pharmacol; 1994 Feb; 47(4):659-65. PubMed ID: 7510479
[TBL] [Abstract][Full Text] [Related]
40. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
